Bruker Introduces Novel HDX Solution for Protein Conformation Studies
San Antonio, Texas, June 6, 2016 – At ASMS 2016, Bruker today announced a new Hydrogen Deuterium Exchange (HDX) workflow on Bruker’s new HDX Solution™. The Bruker HDX Solution enables an automated and reliable HDX-MS workflow combining the LEAP H/D-X PAL™(LEAP Technologies, part of the Trajan family) with Bruker’s market-leading ultra-high mass resolution maXis II ETD UHR-QTOF system, and the Sierra Analytics HDExaminer software. The Bruker HDX Solution delivers correct monoisotopic accurate-mass assignments for quantitative results from H/D ratios, which enables ready access to biomolecular structural insights with greater certainty and confidence.
Photo from Bruker: Key components of the robotic setup for automatic HX-MS experiments
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.